Ulla M. Wewer

Ulla M. Wewer

Professor


  1. Published

    ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome

    Laigaard, J., Spencer, K., Christiansen, M., Cowans, N. J., Larsen, S. O., Pedersen, B. N. & Wewer, Ulla M., 2006, In: Prenatal Diagnosis. 26, 10, p. 973-979 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome

    Christiansen, M., Spencer, K., Laigaard, J., Cowans, N. J., Larsen, S. O. & Wewer, Ulla M., 2007, In: Prenatal Diagnosis. 27, 7, p. 611-615 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage

    Roy, R., Wewer, Ulla M., Zurakowski, D., Pories, S. E. & Moses, M. A., 3 Dec 2004, In: Journal of Biological Chemistry. 279, 49, p. 51323-30 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    ADAM 12 protease induces adipogenesis in transgenic mice.

    Kawaguchi, N., Xu, X., Tajima, R., Kronqvist, P., Sundberg, C., Loechel, F., Albrechtsen, Reidar & Wewer, Ulla M., 2002, In: American Journal of Pathology. 160, 5, p. 1895-903 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3

    Shi, Z., Xu, W., Loechel, F., Wewer, Ulla M. & Murphy, L., 2000, In: Journal of Biological Chemistry. 275, 24, p. 18574-18580

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.

    Loechel, F., Fox, J. W., Murphy, G., Albrechtsen, Reidar & Wewer, Ulla M., 2000, In: Biochemical and Biophysical Research Communications. 278, 3, p. 511-5 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    ADAM12

    Kveiborg, Marie, Fröhlich, C., Albrechtsen, Reidar & Wewer, Ulla M., 29 Aug 2013, Handbook of Proteolytic Enzymes. Elsevier, Vol. 1. p. 1114-1122 9 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  8. Published

    ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice

    Kronqvist, P., Kawaguchi, N., Albrechtsen, Reidar, Xu, X., Schrøder, H. D., Moghadaszadeh, B., Nielsen, Finn Cilius, Frohlich, C., Engvall, E. & Wewer, Ulla M., 1 Nov 2002, In: American Journal of Pathology. 161, 5, p. 1535-40 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation

    Lafuste, P., Sonnet, C., Chazaud, B., Dreyfus, P. A., Gherardi, R. K., Wewer, Ulla M. & Authier, F., 1 Feb 2005, In: Molecular Biology of the Cell. 16, 2, p. 861-70 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling

    Le Pabic, H., Bonnier, D., Wewer, Ulla M., Coutand, A., Musso, O., Baffet, G., Clément, B. & Théret, N., 1 May 2003, In: Hepatology. 37, 5, p. 1056-66 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 914939